Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Repay A	RPAY	5. nov 2024	8.16	+1.24
Repligen	RGEN	5. nov 2024	145.95	+4.60
Replimune Group	REPL	5. nov 2024	12.02	0.00
ReposiTrak	TRAK	5. nov 2024	19.50	+2.79
Republic Bancorp A	RBCAA	5. nov 2024	68.12	+3.17
Republic Services	RSG	5. nov 2024	202.14	+0.77
Research Frontiers	REFR	5. nov 2024	2.15	+0.47
Research Solutions	RSSS	5. nov 2024	2.56	-1.54
Reservoir Media	RSVR	5. nov 2024	8.49	+1.92
ReShape Lifesciences	RSLS	5. nov 2024	6.02	-0.50
Resideo Technologies	REZI	5. nov 2024	20.54	+2.29
ResMed	RMD	5. nov 2024	245.74	+0.87
Resources Connection	RGP	5. nov 2024	8.13	+1.75
Restaurant Brands International	QSR	5. nov 2024	68.20	-2.63
Retail Bull 3X Direxion	RETL	5. nov 2024	9.13	+4.10
Retail ETF Market Vectors	RTH	5. nov 2024	220.31	+0.98
Retail Opportunity Investments	ROIC	5. nov 2024	16.59	-1.25
ReTo Eco-Solutions	RETO	5. nov 2024	1.10	-0.90
Retractable Technologies	RVP	5. nov 2024	0.72	+0.22
REV Group	REVG	5. nov 2024	27.85	+3.03
Revance Therapeutics	RVNC	5. nov 2024	5.84	+0.52
Revelation Biosciences	REVB	5. nov 2024	0.88	+3.35
Revenueshares Largecap	RWL	5. nov 2024	98.16	+0.95
Revenueshares Midcap	RWK	5. nov 2024	117.18	+1.37
Revenueshares Smallcap	RWJ	5. nov 2024	45.56	+2.15
Revenueshares Ultra Dividend Fund	RDIV	5. nov 2024	49.95	+1.03
Reviva Pharmaceuticals	RVPH	5. nov 2024	0.92	-8.29
Revolution Medicines	RVMD	5. nov 2024	56.75	+1.58
Revolve Group A	RVLV	5. nov 2024	26.02	+2.97
Revvity	RVTY	5. nov 2024	125.96	+0.91

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.